QPS检测方法检索器
经验证的检测方法
目前用于药代动力学、药效学和免疫原性的现代生物分析方法大部分基于LC-MS/MS和免疫分析方法。 但是，对于少量重要化合物，用这些技术进行生物分析不尽人意。 一个很好的替代方法是电感耦合等离子体质谱(ICP-MS)。 在ICP-MS中，样本被电感耦合等离子体离子化（离子化源），并使用质谱仪作为分离和检测目标离子的方法。
QPS检测列表含有多种经验证的检测方法，可满足您的全部分析需求。
QPS检测列表含有多种经验证的检测方法，可满足您的全部分析需求。
点击此处搜索检测方法！
Bosutinib
| Matrix: | Human Plasma |
| Assay Range: | 1 - 500 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
Brexpiprazole
| Matrix: | Human Plasma |
| Assay Range: | 0.2 - 80 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antipsychotic |
| Classification: | Drugs |
Brivaracetam
| Matrix: | Human Plasma |
| Assay Range: | 15 - 6,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anticonvulsant |
| Classification: | Drugs |
Bromocriptine
| Matrix: | Human Plasma |
| Assay Range: | 4 - 1000 pg/mL |
| Sample Volume: | 0.6 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Parkinson's Disease |
| Classification: | Drugs |
Brotizolam
| Matrix: | Human Plasma |
| Assay Range: | 50 - 10,000 pg/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Insomnia |
| Classification: | Drugs |
Budesonide
| Matrix: | Human Plasma |
| Assay Range: | 20 to 5,000 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Anti-inflammatory |
| Classification: | Drugs |
Bupivacaine
Dexamethasone
Lidocaine
| Matrix: | Dog Plasma |
| Assay Range: | 5 - 600 ng/mL 0.1 - 50 ng/mL 5 - 600 ng/mL |
| Sample Volume: | 0.15 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drugs |
Buprenorphine
Norbuprenorphine
| Matrix: | Human Plasma |
| Assay Range: | 20 - 5,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drugs |
Bupropion
Hydroxy bupropion
Erythrohydrobupropion
Threohydrobupropion
| Matrix: | Human Plasma |
| Assay Range: | 1 - 500 ng/mL 2.5 - 1,250 ng/mL 1 - 265 ng/mL 3 - 800 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drugs |
Bupropion
Hydroxy Bupropion
| Matrix: | Human Plasma |
| Assay Range: | 1 - 200 ng/mL 1 - 800 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drugs |
Bupropion
Hydroxy Bupropion
| Matrix: | Human Plasma |
| Assay Range: | 0.2 - 200 ng/mL 0.5 - 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drugs |
Bupropion
| Matrix: | Human Plasma |
| Assay Range: | 1 - 200 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drugs |
Butyl Scopolamine
| Matrix: | Human Plasma |
| Assay Range: | 2 - 2,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anticholinergic and antispasmodic |
| Classification: | Drugs |
c-Met / Hepatocyte Growth Factor Receptor 1 (HGF-R1)
| Matrix: | Human Plasma |
| Assay Range: | 1.56 - 25 ng/mL |
| Sample Volume: | 0.200 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biomarkers |
C-peptide
| Matrix: | Human Serum |
| Assay Range: | 115 - 4,250 pmol/L |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N/A |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biomarkers |
C-reactive protein (CRP)
| Matrix: | Human Plasma |
| Assay Range: | 0.781 - 50.0 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Metabolic, Vascular, Cardiovascular |
| Classification: | Biomarkers |
Cabozantinib
| Matrix: | Human Serum |
| Assay Range: | 1 - 1,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N/A |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
Caffeine
1,7-Dimethylxanthine
| Matrix: | Human Plasma |
| Assay Range: | 0.02 - 20 ug/mL 0.02 - 20 ug/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drugs |
Caffeine
1,7-Dimethylxanthine
| Matrix: | Human Plasma |
| Assay Range: | 30.0 - 20,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -80 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drugs |
Caffeine
Paraxanthine
1-Methylxanthine
AAMU
1-Methyluric Acid
1,7-Dimethyluric Acid
| Matrix: | Human Urine |
| Assay Range: | 0.02 - 10 μg/mL 0.05 - 25 μg/mL 0.05 - 25 μg/mL 0.05 - 25 μg/mL 0.1 - 50 μg/mL 0.1 - 50 μg/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N/A |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drugs |
Caffeine
| Matrix: | Human Plasma |
| Assay Range: | 20 - 5,000 ng/mL |
| Sample Volume: | 0.1mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drugs |
Candesartan
Hydrochlorothiazide
| Matrix: | Human Plasma |
| Assay Range: | 5 - 800 ng/mL 2.5 - 500 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drugs |
Candesartan
| Matrix: | Human Plasma |
| Assay Range: | 1 - 200 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drugs |
Capecitabine
| Matrix: | Human Plasma |
| Assay Range: | 20 - 12,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
Capmatinib
| Matrix: | Human Plasma |
| Assay Range: | 10 - 6,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drugs |
点击此处下载免费的APPLE或ANDROID APP！
